Therefore, the impairments in SorCS1-dependent APP catabolism, trafficking of adhesion molecules, neurotransmitter receptors and trophic receptors may jointly cause synaptic dysfunction, synapse loss and neurodegeneration in AD patients. This evidence concerns the gene SORCS1 and Alzheimer disease.